These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9920141)

  • 21. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in diabetes mellitus.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Acta Diabetol; 1998 Oct; 35(3):158-60. PubMed ID: 9840453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to its extent.
    Lo Presti R; Tozzi Ciancarelli MG; Canino B; Carollo C; Lucido D; Amodeo G; Romano A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):199-201. PubMed ID: 16899927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide is not involved in hepatocyte killing by neutrophils activated by N-formyl-methionyl-leucylphenylalanine or phorbol myristate acetate in vitro.
    Wagner JG; Ganey PE; Roth RA
    Hepatology; 1996 Apr; 23(4):803-10. PubMed ID: 8666335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
    Quitt M; Torres M; McGuire W; Beyer L; Coates TD
    J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of polymorphonuclear leukocyte membrane fluidity: effect of cytoskeletal modification.
    Wiles ME; Dykens JA; Wright CD
    J Leukoc Biol; 1994 Aug; 56(2):192-9. PubMed ID: 7915297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric study of the activation of polymorphonuclear cells.
    Belloc F; Vincendeau P; Freyburger G; Dumain P; Boisseau MR
    J Leukoc Biol; 1990 Oct; 48(4):353-8. PubMed ID: 2394945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences and similarities between human and rabbit neutrophil granulocyte responses in vitro: the effects of zymosan-activated plasma, phorbol myristate acetate and n-formyl-methionyl-leucyl-phenylalanine.
    Opdahl H; Benestad HB; Nicolaysen G
    Acta Anaesthesiol Scand; 1987 Aug; 31(6):491-8. PubMed ID: 3630594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.
    Anderson DC; Hughes BJ; Smith CW
    J Clin Invest; 1981 Oct; 68(4):863-74. PubMed ID: 7287906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic renal failure: behaviour of the polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
    Caimi G; Canino B; Vaccaro F; Ventimiglia G; Oddo G; Montana M; Lo Presti R
    Nephrol Dial Transplant; 1999 Jan; 14(1):253-4. PubMed ID: 10052535
    [No Abstract]   [Full Text] [Related]  

  • 33. Abnormal membrane fluidity as a cause of impaired functional dynamics of chemoattractant receptors on neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by a membrane fluidizer.
    Yasui K; Masuda M; Matsuoka T; Yamazaki M; Komiyama A; Akabane T; Hasui M; Kobayashi Y; Murata K
    Pediatr Res; 1988 Oct; 24(4):442-6. PubMed ID: 2845343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
    Caimi G; Lo Presti R; Canino B; Montana M; Cerasola G
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):947-8. PubMed ID: 10509556
    [No Abstract]   [Full Text] [Related]  

  • 35. Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension.
    Caimi G; Presti RL; Carollo C; Musso M; Porretto F; Canino B; Catania A; Cerasola G
    Hypertension; 2000 Nov; 36(5):813-7. PubMed ID: 11082148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of oxidative burst and degranulation of porcine neutrophils by a homologous spleen galectin-1 compared to N-formyl-L-methionyl-L-leucyl-L-phenylalanine and phorbol 12-myristate 13-acetate.
    Elola MT; Chiesa ME; Fink NE
    Comp Biochem Physiol B Biochem Mol Biol; 2005 May; 141(1):23-31. PubMed ID: 15820131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphonuclear leukocyte integrins in deep venous thrombosis.
    Caimi G; Canino B; Ferrara F; Montana M; Lo Presti R
    Clin Appl Thromb Hemost; 2005 Jan; 11(1):95-7. PubMed ID: 15678279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of polymorphonuclear leukocyte function by Legionella pneumophila exoproducts.
    Sahney NN; Lambe BC; Summersgill JT; Miller RD
    Microb Pathog; 1990 Aug; 9(2):117-25. PubMed ID: 2177516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-associated changes of neutrophil responsiveness in a human healthy elderly population.
    Polignano A; Tortorella C; Venezia A; Jirillo E; Antonaci S
    Cytobios; 1994; 80(322):145-53. PubMed ID: 7774287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.